Diet-based Inhibition of Acetylcholinesterase as a Treatment for Myasthenia Gravis and Alzheimer’s Disease
Overview
Myasthenia Gravis (MG) is an autoimmune and neurodegenerative disorder characterized by disturbances in nerve-muscle communication caused by auto-immune system complications. Antibodies mistake muscle acetylcholine receptors as foreign invaders and block the binding of acetylcholine (ACh) thereby preventing the signal for muscle activation. Alzheimer’s Disease (AD) is characterized by a decreased production of ACh. The enzyme acetylcholinesterase (AChE) normally degrades ACh in order to turn off its signal. Current treatments for MG and AD involve synthetic AChE-inhibitors such as Pyridostigmine. These drugs increase the amount of ACh in the gap by slowing its degradation, effectively increasing the chances of successful nerve-muscle communication. The goal of this research is to find additional AChE-inhibitors in foods that may help to supplement MG and AD treatment. Extracts of various fruits and vegetables were made and tested in a spectrophotometric based AChE-inhibition assay. Concentrations of each extract required for 50% inhibition (IC50 values) and rates of AChE activity were calculated in order to quantitatively compare their AChE-inhibiting properties. Preliminary data analysis suggests that brussel sprouts, broccoli, pear, pomegranate, and bok choy are the most potent natural inhibitors. Further analysis of their methods of inhibition is underway. These findings demonstrate that natural AChE-inhibitors exist in foods and a structured diet could be used to augment MG and AD treatment.
Competition history
- ISEF 2014
Resources
Related projects
ISEF · 2018
The Plausibility of Using Plant Based Extracts as Acetylcholinesterase Inhibitors
ISEF · 2021
Assessing the Effectiveness of the Hericium erinaceus Extract as Acetylcholinesterase Inhibitors
ISEF · 2016
The Evaluation of Eggplant Leaves as a Potential Anti-Alzheimer Activity
ISEF · 2026
Discovering a Path from Molecular Modeling to Alzheimer's Phytotherapeutics: Characterizing Novel GSK3ß Inhibitors in silico and in vitro
ISEF · 2016
Inhibition of the Amyloid Processing Pathway by Micronutrients: A Systematic Genome-Wide Chemical Repositioning Approach to Counteract Alzheimer's Pathology
ISEF · 2014
Nicotine and Genistein as Novel Therapeutic Agents for Alzheimer's Disease
ISEF · 2024
Synthesizing a Novel Family of Multifactorial Inhibitors to Treat Alzheimer's
ISEF · 2025
Inhibition of Salivary ALPHA-Amylase by a Bistorta major (S. F. Gray) Extract as a Therapeutic Strategy for the Treatment of Diabetes Mellitus
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair